Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
Fortrea (NASDAQ:FTRE) had its "hold" rating reaffirmed by analysts at TD Cowen.
Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE
Why Fortrea (FTRE) Stock Is Trading Up Today [Yahoo! Finance]